Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
765 - I believe there is a condition in the code that we can have APS reviewed/approved by PAAB even before NOC ? Where can I find this in the code for proper guidance. Thanks.
-
PAAB will provide review of up to a maximum of two core pieces prior to NOC only when the Product Monograph has reached the final-draft stage. As per the guidance documents mentioned below, advertisers should be aware that under PAAB's mandate, we can only provide acceptances for advertising for use post-NOC. PAAB does not issue acceptances for any branded promotional activities carried on pre-NOC. Guidance can be found on the PAAB website under resources: Administrative Guideline for the Review of Pre-NOC Advertising Submissions and Chapter 5 of Guidance on Submission Process
